Home Dermatology PDF: Deuruxolitinib for Alopecia Areata
Article
PDF: Deuruxolitinib for Alopecia Areata
$1.99
PDF Download: Deuruxolitinib (FDA-approved July 2024) is an oral JAK1/JAK2 inhibitor for severe alopecia areata. Learn about its mechanism, THRIVE-AA trial results showing rapid hair regrowth, safety profile, and how it compares to baricitinib and ritlecitinib.
Read online:
Deuruxolitinib for Alopecia Areata
